Skip to main content

Xiaojing Liu

XL
Xiaojing Liu

Associate Professor

Goodnight Early Career Innovator

Molecular and Structural Biochemistry

LC-HRMS Multi-Omics Workflows

359 Polk Hall

919.515.4387

Bio

Research Interests

I am a bioanalytical chemist investigating the fundamental principles of metabolic regulation within intestinal tissues. Operating on the philosophy that metabolic rewiring is a primary driver of disease dynamics—not just a passenger—my research program spans cellular biochemistry to whole-organism physiology to decode complex pathologies. Core research areas include:

  • Advanced Multi-Omics Workflows: Pioneering integrative liquid chromatography–high-resolution mass spectrometry (LC-HRMS) pipelines across metabolomics, lipidomics, proteomics, and phosphoproteomics in both cell-based and whole-organism models.
  • Intestinal Metabolic Regulation: Investigating how localized metabolic shifts and tissue-specific mitochondrial function govern systemic health and disease.
  • Mechanistic Analysis of Drug Action: Bridging cellular biochemistry with organ-specific responses, with a particular focus on how mitochondrial fuel plasticity dictates drug sensitivity (e.g., metformin).
  • Stable Isotope Flux Analysis: Developing sophisticated in vitro and in vivo tracing methodologies (using 13C-glucose, 13C-glutamine, and 18O tracing) to quantitatively map pathway contributions to specific biological targets.

Education

B.S. Chemistry University of Science and Technology of China 2007

Ph.D. Chemistry University of Pennsylvania 2012

Post-Doctoral Pharmacology and Cancer Biology Duke University

Area(s) of Expertise

Multi-Omics for Drug Mechanisms

Publications

View all publications